CompletedPhase 1

MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors

United States7 participantsStarted 2014-04

Plain-language summary

The purpose of this study is to determine if Magnetic Resonance guided High Intensity Focused Ultrasound ablative therapy is safe and feasible for children, adolescents, and young adults with refractory or relapsed solid tumors.

Who can participate

Age range30 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Peripheral absolute neutrophil count (ANC) of ≥750/µL
✓. Platelet count ≥75,000/µL (may receive transfusions)

What they're measuring

Toxicity

Timeframe: 28 days following ablative therapy

Trial details

NCT IDNCT02076906

SponsorAeRang Kim

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12-27

View on ClinicalTrials.gov More Relapsed Pediatric Solid Tumors trials